https://www.selleckchem.com/products/ti17.html
ntrol group, Xuebijing injection group shortened the abdominal pain and distension relief time in AP patients (WMD = -1.69, 95% CI -1.88--1.50, p less then 0.0001; WMD = -1.48, 95% CI -1.74--1.23, p less then 0.0001), with high heterogeneity (I2 = 84.3%, p = 0.000; I2 = 72.2%, p = 0.00. Serum amylase level was also reduced (WMD = -2.06, 95% CI -2.47--1.64, p less then 0.0001), with significant heterogeneity (I2 = 71.6%, p = 0.00. A total of one SR reported adverse drug reaction (ADR), no ADRs were observed in the control group. Conclus
Like
Comment
Share
